Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Updated Results of Phase I/II MMRC Trial - Jakubowiak, Andrzej J.; Reece, Donna E.; Hofmeister, Craig C.; Lonial, Sagar; Zimmerman, Todd M.; Campagnaro, Erica L.; Schlossman, Robert L.; Laubach, Jacob; Raje, Noopur; Anderson, Tara; Griffith, Kent; Hill, Melissa; et al. (Blood, 2009)